Nebula Research & Development’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.88M | Buy |
60,223
+13,662
| +29% | +$428K | 0.16% | 205 |
|
|
2025
Q1 | $1.56M | Buy |
46,561
+26,201
| +129% | +$879K | 0.14% | 232 |
|
|
2024
Q4 | $798K | Sell |
20,360
-3,905
| -16% | -$153K | 0.09% | 372 |
|
|
2024
Q3 | $955K | Sell |
24,265
-5,931
| -20% | -$234K | 0.11% | 303 |
|
|
2024
Q2 | $1.18M | Buy |
+30,196
| New | +$1.18M | 0.19% | 170 |
|
|
2024
Q1 | – | Sell |
-7,281
| Closed | -$335K | – | 1026 |
|
|
2023
Q4 | $335K | Buy |
+7,281
| New | +$335K | 0.1% | 402 |
|